Navigation Links
BioPrime Plus Array CGH Indirect Genomic Labeling Module from Invitrogen

ProductsBioPrime Plus Array CGH Indirect Genomic Labeling Module from Invitrogen
Company Invitrogen
Item BioPrime Plus Array CGH Indirect Genomic Labeling Module
Price 
Description The BioPrime Plus Array CGH Genomic Labeling Systems are a high-performance labeling kits that enable reproducible labeling of genomic DNA samples for array-based Comparative Genomic Hybridization (CGH). Available in both indirect and direct labeling formats, the BioPrime Plus Array CGH Genomic Labeling Systems provide a flexible solution to your genomic labeling needs.


Using the BioPrime Plus Array CGH Genomic Labeling Systems, you can expect:
High yields of fluorescently labeled genomic DNA • signal-to-noise ratios • detection of gene copy number variations.

These systems combine a highly concentrated exo-Klenow fragment of DNA polymerase I and random primers to effectively label genomic targets for sensitive genomic profiling experiments. Exo-Klenow is a mutant of the large fragment of the DNA polymerase I holoenzyme that has both 5 and 35 exonuclease activity removed. The lack of exonuclease activity makes this enzyme ideal for use in random priming protocols, enabling robust yields and efficient incorporation of Alexa Fluor AHA fluorescent nucleotides. In the BioPrime Plus Array CGH Genomic Labeling Systems, random octamers anneal to template DNA, providing priming sites for the exo- Klenow enzyme. Alexa Fluor AHA modified nucleotides (direct labeling) or amino-allyl modified nucleotides (indirect labeling) are incorporated as the polymerase extends from the priming sites. The labeled samples are then purified to remove contaminants prior to denaturing and hybridization to a microarray (direct labeling systems) or coupled to the Alexa Fluor NHS ester (indirect labeling systems) prior to hybridization.

Contents:
The BioPrime Core Module is found in all standard BioPrime and BioPrime Plus Systems and Modules. It contains exo-Klenow fragment (40 U/ l), 2.5X random primer solution (octamers), control DNA (Salmon Sperm), stop buffer, and distilled water. Store at -20C. The BioPrime Plus Systems and Modules contain the Alexa Fluor modified dNTP mixes or amine modified dNTP mixes and the Alexa Fluor NHS Esters. Store at -20C. The standard BioPrime and BioPrime Plus Array CGH Genomic Labeling Systems also contain purification columns and purification buffers.
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. BioPrime Array CGH Genomic Labeling System from Invitrogen
2. BioPrime Array CGH Genomic Labeling Module from Invitrogen
3. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies
4. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies
5. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies
6. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Brain (adult) from OriGene Technologies
7. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Embryo (12.5 - day) from OriGene Technologies
8. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Embryo (19 - day) from OriGene Technologies
9. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Thymus from OriGene Technologies
10. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Rat Brain (adult) from OriGene Technologies
11. eArray from Agilent Technologies
Goat HRP-AEC Cell & Tissue Staining Kit from R&D Systems
RiboCap™ from RNAture, Inc.
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Equine Immunoglobulin G from Equitech-Bio
Biology Products:
(Date:11/23/2009)...CT Current research suggests that a common oral b...elated report by Nichols et al, "Unique Lipids fro...f TLR2 Ligands Capable of Enhancing Autoimmunity,"...an Journal of Pathology . , Multiple sclerosis (... brain and spinal cord, affects nearly 1 in 700 pe...
(Date:11/23/2009)... - The only swine vaccine available for the H1N1 v...ted with the virus. The vaccination marks the firs...osed with the pandemic flu., Iowa State Universi...eloped the vaccine this summer and has been shippi...nsas and Illinois for several weeks., The latest...
(Date:11/23/2009)... November 16, 2009 -- A USDOE and USDA study concl...cropland, and cropland pasture could be converted ...rasses, such as switchgrass, from which biomass co...conomically viable production of a perennial grass...biomass are removed annually is expected to requir...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 1Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 2Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 3MedQuist Adds Kevin Piltz as New Chief Information Officer 49424 1MedQuist Adds Kevin Piltz as New Chief Information Officer 49424 2ERT Officials Ring the NASDAQ Closing Bell 49422 1ERT Officials Ring the NASDAQ Closing Bell 49422 2ERT Officials Ring the NASDAQ Closing Bell 49422 3
...a has been outsmarting the human immune system for...malaria infections in live mice, researchers have ...-using dead liver cells to cloak and transport its...ver. , Robert Ménard, a Howard Hughes Medical Ins...his postdoctoral fellow, Rogerio Amino, at the Ins...
...unusually rigorous scientific conditions and measu... active agent in "sacred mushrooms" can induce mys...l to spontaneous ones people have reported for cen...rompt positive changes in behavior and attitude th...a plant alkaloid called psilocybin, mimics the eff...
...ists have demonstrated for the first time that emb...can produce sperm with the capacity to produce via... issue of Developmental Cell, opens many exciting ...n of mechanisms involved in sperm production and d...lity. , Previous studies have shown that ES cells ...
Other Biology News:Movie spies on malaria parasite's sneaky behavior 2Movie spies on malaria parasite's sneaky behavior 3Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 2Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 3Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 4Sperm created in the laboratory from embryonic stem cells produce viable progeny 2
(Date:11/24/2009)... Shire plc (LSE: SHP,NA...ical company, today,announced that it has submitte...lucerase alfa, the company,s enzyme replacement th...aucher disease. This is the third marketing,applic...ed, with previous,submissions in the United States...
(Date:11/24/2009)...Nov. 24 Genomic Health, ...cott, Genomic Health,s Executive Chairman, will pr... Conference in New York City on Tuesday, December ...e and subsequently archived webcast of the present...omic Health,s website at http://investor.genomich...
(Date:11/24/2009)...nnects Customers with Partners Validated to Proces...roducts , Ottawa, ON (PRW...provider of products for biological sample collect...d its new global partner program. The program offe...ner community and is designed to help partners sca...
(Date:11/24/2009)...Newswire-FirstCall/ -- Cell Therapeutics, Inc. (CT...at the 21st Annual Piper Jaffray Health Care Confe...009, at the New York Palace Hotel. ,, CTI wil...tern Time in Holmes 1 (4th Floor). A live audio we...www.celltherapeutics.com , and it will also be ava...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3